Registry Search

8,240 Clinical Drug Overviews

Medication	Therapeutic Class	Generic Mapping	Safety
EDETATE CALCIUM DISODIUM Comprehensive clinical and safety monograph for EDETATE CALCIUM DISODIUM (EDETATE CALCIUM DISODIUM).	Chelating Agent	EDETATE CALCIUM DISODIUM	caution
EDEX Comprehensive clinical and safety monograph for EDEX (EDEX).	Erectile Dysfunction Agent	EDEX	caution
EDLUAR Comprehensive clinical and safety monograph for EDLUAR (EDLUAR).	Sedative-Hypnotic	EDLUAR	caution
EDOXABAN Comprehensive clinical and safety monograph for EDOXABAN (EDOXABAN).	Anticoagulant	EDOXABAN	caution
EDROPHONIUM CHLORIDE Comprehensive clinical and safety monograph for EDROPHONIUM CHLORIDE (EDROPHONIUM CHLORIDE).	Cholinesterase Inhibitor	EDROPHONIUM CHLORIDE	caution
EDROPHONIUM CHLORIDE PRESERVATIVE FREE Comprehensive clinical and safety monograph for EDROPHONIUM CHLORIDE PRESERVATIVE FREE (EDROPHONIUM CHLORIDE PRESERVATIVE FREE).	Cholinesterase Inhibitor	EDROPHONIUM CHLORIDE PRESERVATIVE FREE	caution
EDURANT Comprehensive clinical and safety monograph for EDURANT (EDURANT).	NNRTI Antiretroviral	EDURANT	caution
EDURANT PED Comprehensive clinical and safety monograph for EDURANT PED (EDURANT PED).	NNRTI Antiretroviral	EDURANT PED	caution
EFAVIRENZ Induces CYP3A4 and inhibits CYP2C9/CYP2C19 affecting many drugs Can cause severe psychiatric symptoms and rash.	NNRTI	EFAVIRENZ	avoid
EFAVIRENZ 200MG SCORED TABLETS Induces CYP3A4 and inhibits CYP2C9/CYP2C19 affecting many drugs Can cause severe psychiatric symptoms and rash.	NNRTI	EFAVIRENZ 200MG SCORED TABLETS	avoid
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE	safe
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE	safe
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE	safe
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	safe
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	safe
EFFEXOR Comprehensive clinical and safety monograph for EFFEXOR (EFFEXOR).	SNRI Antidepressant	EFFEXOR	caution
EFFEXOR XR Comprehensive clinical and safety monograph for EFFEXOR XR (EFFEXOR XR).	SNRI Antidepressant	EFFEXOR XR	caution
EFFIENT Comprehensive clinical and safety monograph for EFFIENT (EFFIENT).	Antiplatelet Agent	EFFIENT	caution
EFIDAC 24 CHLORPHENIRAMINE MALEATE Comprehensive clinical and safety monograph for EFIDAC 24 CHLORPHENIRAMINE MALEATE (EFIDAC 24 CHLORPHENIRAMINE MALEATE).	Antihistamine	EFIDAC 24 CHLORPHENIRAMINE MALEATE	caution
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE MAOIs can cause hypertensive crisis Can cause insomnia and tachycardia.	Sympathomimetic	EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE	safe
EFINACONAZOLE Comprehensive clinical and safety monograph for EFINACONAZOLE (EFINACONAZOLE).	Antifungal Agent	EFINACONAZOLE	caution
EFUDEX Comprehensive clinical and safety monograph for EFUDEX (EFUDEX).	Topical Antineoplastic	EFUDEX	caution
EGATEN Comprehensive clinical and safety monograph for EGATEN (EGATEN).	Antiprotozoal Agent	EGATEN	caution
EGRIFTA Comprehensive clinical and safety monograph for EGRIFTA (EGRIFTA).	Growth Hormone Releasing Hormone Analog	EGRIFTA	caution
EKTERLY Comprehensive clinical and safety monograph for EKTERLY (EKTERLY).	Antineoplastic Agent	EKTERLY	caution
ELAGOLIX Comprehensive clinical and safety monograph for ELAGOLIX (ELAGOLIX).	Gonadotropin-Releasing Hormone Antagonist	ELAGOLIX	caution
ELAHERE Comprehensive clinical and safety monograph for ELAHERE (ELAHERE).	Antineoplastic Agent	ELAHERE	caution
ELAPRASE Comprehensive clinical and safety monograph for ELAPRASE (ELAPRASE).	Enzyme Replacement Therapy	ELAPRASE	caution
ELASE-CHLOROMYCETIN Comprehensive clinical and safety monograph for ELASE-CHLOROMYCETIN (ELASE-CHLOROMYCETIN).	Topical Antibiotic and Debriding Agent	ELASE-CHLOROMYCETIN	caution
ELAVIL Comprehensive clinical and safety monograph for ELAVIL (ELAVIL).	Tricyclic Antidepressant	ELAVIL	caution
ELCYS Comprehensive clinical and safety monograph for ELCYS (ELCYS).	Amino Acid Supplement	ELCYS	caution
ELDECORT Comprehensive clinical and safety monograph for ELDECORT (ELDECORT).	Topical Corticosteroid	ELDECORT	caution
ELDEPRYL Comprehensive clinical and safety monograph for ELDEPRYL (ELDEPRYL).	Monoamine Oxidase Inhibitor	ELDEPRYL	caution
ELELYSO Comprehensive clinical and safety monograph for ELELYSO (ELELYSO).	Enzyme Replacement Therapy	ELELYSO	caution
ELEPSIA XR Comprehensive clinical and safety monograph for ELEPSIA XR (ELEPSIA XR).	Antiepileptic	ELEPSIA XR	caution
ELESTAT Comprehensive clinical and safety monograph for ELESTAT (ELESTAT).	Ophthalmic Antihistamine	ELESTAT	caution
ELESTRIN Comprehensive clinical and safety monograph for ELESTRIN (ELESTRIN).	Estrogen Replacement Therapy	ELESTRIN	caution
ELETRIPTAN HYDROBROMIDE Strong CYP3A4 inhibitors (eg ketoconazole) are contraindicated due to increased risk of coronary vasospasm Contraindicated in ischemic heart disease and uncontrolled hypertension.	5-HT1 Agonist	ELETRIPTAN HYDROBROMIDE	avoid
ELFABRIO Comprehensive clinical and safety monograph for ELFABRIO (ELFABRIO).	Enzyme Replacement Therapy	ELFABRIO	caution
ELIDEL Comprehensive clinical and safety monograph for ELIDEL (ELIDEL).	Topical Calcineurin Inhibitor	ELIDEL	caution
ELIFEMME Comprehensive clinical and safety monograph for ELIFEMME (ELIFEMME).	Oral Contraceptive	ELIFEMME	caution
ELIGARD KIT Comprehensive clinical and safety monograph for ELIGARD KIT (ELIGARD KIT).	GnRH Agonist Antineoplastic	ELIGARD KIT	caution
ELIGLUSTAT TARTRATE Comprehensive clinical and safety monograph for ELIGLUSTAT TARTRATE (ELIGLUSTAT TARTRATE).	Glucosylceramide Synthase Inhibitor	ELIGLUSTAT TARTRATE	caution
ELIMITE Comprehensive clinical and safety monograph for ELIMITE (ELIMITE).	Topical Scabicide	ELIMITE	caution
ELINEST Comprehensive clinical and safety monograph for ELINEST (ELINEST).	Oral Contraceptive	ELINEST	caution
ELIPHOS Comprehensive clinical and safety monograph for ELIPHOS (ELIPHOS).	Antacid	ELIPHOS	caution
ELIQUIS Comprehensive clinical and safety monograph for ELIQUIS (ELIQUIS).	Factor Xa Inhibitor	ELIQUIS	caution
ELIQUIS SPRINKLE Comprehensive clinical and safety monograph for ELIQUIS SPRINKLE (ELIQUIS SPRINKLE).	Factor Xa Inhibitor	ELIQUIS SPRINKLE	caution
ELITEK Comprehensive clinical and safety monograph for ELITEK (ELITEK).	Uricolytic Agent	ELITEK	caution
ELIXICON Comprehensive clinical and safety monograph for ELIXICON (ELIXICON).	Xanthine Bronchodilator	ELIXICON	caution

Showing 2351 - 2400 of 8245

Previous Next